Related Experiment Videos
Clinical study of sandimmun neoral in cadaveric renal transplantation
1Department of Renal Transplants, First Clinical Medical College of Xi'an Medical University, People's Republic of China.
Transplantation Proceedings
|June 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Mechanistic study on alleviation of Schistosoma japonicum infection-induced hepatic damages by macrophage efferocytosis].
Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control·2026
Cardiopulmonary exercise testing as an integrative approach to explore physiological limitations in Duchenne muscular dystrophy.
Journal of neuromuscular diseases·2025
[Research progress on the epidemiological characteristics and prevention and control of severe fever with thrombocytopenia syndrome].
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2025
The Role of Varying Cardiac Troponin Levels in Long-Term Mortality in Liver Transplant Patients.
Transplantation proceedings·2026
Evaluation of Scoring Systems in Kidney Transplantation: A Single Center Experience.
Transplantation proceedings·2026
Fat Embolism Syndrome as Cause of Death in a Multiorgan Donor With Successful Utilization of Thoracic and Abdominal Organs.
Transplantation proceedings·2026
Mechanical circulatory support devices in heart failure: a narrative review of current evidence, clinical applications, complications, and future directions.
Frontiers in cardiovascular medicine·2026
Pharmacotherapy for MASLD/MASH: approved therapies, drug repurposing, and emerging mechanism-based candidates.
Expert opinion on pharmacotherapy·2026
Effectiveness and safety of three years of bulevirtide monotherapy in patients with HDV-related compensated cirrhosis: the Italian compassionate use program.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Long-term outcomes of alemtuzumab in relapsing-remitting multiple sclerosis: a real-world cohort with particular focus on treatment sequencing after natalizumab.
Journal of the neurological sciences·2026